Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo

European Journal of Pharmacology

Volumn 499, Issue 1-2, 2004, Pages 163-169

  Iliodromitis, Efstathios K ^a   Tasouli, Androniki ^a   Andreadou, Ioanna ^a   Bofilis, Elias ^a   Zoga, Anastasia ^a   Cokkinos, Philip ^a   Kremastinos, Dimitrios Th ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Adrenoreceptor antagonists; Infarction; Preconditioning

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CADMIUM; ESMOLOL; SHORT ACTING DRUG; TETRAZOLIUM; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FLUORESCENCE ANALYSIS; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART PROTECTION; HEART RATE; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; RESPONSE TIME; RISK ASSESSMENT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; HEMODYNAMIC PHENOMENA; INFUSIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PROPANOLAMINES; RABBITS; SURVIVAL RATE; TIME FACTORS;

EID: 19344378670     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.093     Document Type: Article

References (46)

1. A. Banerjee, C. Locke-Winter, K.B. Rogers, M.B. Mitchell, E.C. Brew, C.B. Cairns, D.D. Bensard, and A.H. Harken Preconditioning against myocardial dysfunction after ischemia and reperfusion by a α1-adrenergic mechanism Circ. Res. 73 1993 656 670
2. C. Casati, A. Forlani, G. Lozza, and A. Monopoli Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit Pharmacol. Res. 35 1997 51 55
3. J.C. Cleveland, D.R. Meldrum, R.T. Rowland, B.S. Cain, X. Meng, F. Gamboni-Robertson, A. Benerjee, and A.H. Harken Ischemic preconditioning in human myocardium: protein kinase C mediates a permissive role for alpha adrenoreceptors Am. J. Physiol. 273 1997 H902 H908
4. M.V. Cohen, S.M. Yang, and J.M. Downey Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning Circ. Res. 74 1994 998 1004
5. M.V. Cohen, Y. Liu, G. Liu, P. Wang, C. Weinbrenner, G. Cordis, D. Das, and J. Downey Phospholipase D plays a role in ischemic preconditioning in rabbit heart Circulation 94 1996 1713 1718
6. S. De Zeeuw, T.W. Lameris, D.J. Duncker, D. Hasan, F. Boomsma, A.H. van de Meiracker, and P.D. Verdouw Cardioprotection in pigs by exogenous norepineprhine but not cerebral ischemia-induced release of endogenous norepinephrine Stroke 32 2001 767 774
7. G. Feuerstein, G.-L. Liu, T.-L. Uue, H.-Y. Cheng, J.P. Hieble, J.R.S. Arch, R.R. Ruffolo, and X-L. Ma Comparison of metorprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model Eur. J. Pharmacol. 351 1998 341 350
8. F. Gao, J. Chen, B.L. Lopez, T.A. Christopher, J. Gu, P. Lysko, R.R. Ruffolo, E.H. Ohlstein, X.L. Ma, and T.-L. Yue Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model Eur. J. Pharmacol. 406 2000 109 116
9. D. Garcia-Dorado, M. Ruiz-Meana, F. Padilla, A. Rodrigues-Sinovas, and M. Mirabet Gap junction-mediated intercellular communication in ischemic preconditioning Cardiovasc. Res. 55 2002 456 465
10. M. Goto, Y. Liu, X.M. Yang, J.L. Ardell, M.V. Cohen, and J.M. Downey Role of bradykinin in protection of ischemic preconditioning in rabbit hearts Circ. Res. 77 1995 611 621
11. P. Htun, W.D. Ito, I.E. Hoefer, J. Schaper, and W. Schaper Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium J. Mol. Cell. Cardiol. 30 1998 867 877
12. K. Hu, D. Duan, G.R. Li, and S. Nattel Protein kinase C activates ATP-sensitive K+ current in human and rabbit ventricular myocytes Circ. Res. 78 1996 492 498
13. E.K. Iliodromitis, D.T. Kremastinos, D.G. Katritsis, C.C. Papadopoulos, and D.J. Hearse Multiple cycles of preconditioning cause loss of protection in open-chest rabbits J. Mol. Cell. Cardiol. 29 1997 915 920
14. E.K. Iliodromitis, T. Miki, G.S. Liu, J.M. Downey, M.V. Cohen, and D.T. Kremastinos The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: is 5′-nucleotidase important? J. Mol. Cell. Cardiol. 30 1998 2201 2211
15. E.K. Iliodromitis, P. Cokkinos, A. Zoga, I. Steliou, A.R. Vrettou, and D.T. Kremastinos Oral nicorandil recaptures the waned protection from preconditioning in vivo Br. J. Pharmacol. 138 2003 1101 1106
16. International Collaborative Study Group Reduction of infarct size with the early use of timolol in acute myocardial infarction N. Engl. J. Med. 310 1984 9 15
17. R.A. Kloner, R. Bolli, E. Marban, L. Reinlib, and E. Braunwald Medical and cellular implications of stunning, hibernation, and preconditioning. An NHLBI Workshop Circulation 97 1998 1848 1867
18. C.S. Lawson, D.J. Coltart, and D.J. Hearse "Dose"-dependency and temporal characteristics of protection by ischemic preconditioning against ischemia-induced arrhythmias in rat hearts J. Mol. Cell. Cardiol. 25 1993 1391 1402
19. Y. Li, and R.A. Kloner The cardioprotective effects of ischemic "preconditioning" are not mediated by adenosine receptors in rat hearts Circulation 87 1993 1642 1648
20. D.A. Liem, M.A. van den Doel, S. de Zeeuw, P.D. Verdouw, and D.J. Duncker Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors Cardiovasc. Res. 51 2001 701 708
21. R. Lim, and W.K. Laskey Ischemic preconditioning in unstable coronary syndromes: evidence for time dependence J. Am. Coll. Cardiol. 30 1997 1461 1465
22. G.S. Liu, J. Thornton, D.M. Van Winkle, A.W.H. Stanley, R.A. Olsson, and J.M. Downey Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart Circulation 84 1991 350 356
23. A. Lochner, S. Genade, E. Tromp, T. Podzuweit, J.A. Moolman, and M. Med Ischemic preconditioning and the β-adrenergic signal transduction pathway Circulation 100 1999 958 966
24. Y. Nasa, K. Yabe, and S. Takeo β-Adrenoreceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts J. Cardiovasc. Pharmacol. 29 1997 436 443
25. F. Ottani, M. Galvani, D. Ferrini, F. Sorbello, P. Limonetti, D. Pantoli, and F. Rusticali Prodroma angina limits infarct size; a role for ischemic preconditioning Circulation 91 1995 291 297
26. L.M. Prissant, J.L. Houghton, P.B. Bottini, and A.A. Carr Unstable angina: pharmaceutical versus invasive therapy Postgrad. Med. 96 1994 88 95
27. R. Sandhu, R.J. Diaz, G.D. Mao, and G.J. Wilson Ischemic preconditioning. Differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia Circulation 96 1997 984 995
28. A.T. Saurin, J.L. Matin, R.J. Heads, C. Foley, J.W. Mockridge, M.J. Wright, Y. Wang, and M.S. Marber The role of differential activation of p-38-mitogen-activated protein kinase in preconditioned ventricular myocytes FASEB J. 14 2000 2237 2246
29. J.J. Schultz, A.K. Hsu, and G.J. Gross Ischemic preconditioning and morhine-induced cardioprotection through bradykinin B2 receptor activation in human heart J. Am. Coll. Cardiol. 29 1997 2187 2195
30. R. Schultz, H. Post, C. Vahlhaus, and G. Heusch Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin Circulation 98 1998 1022 1029
31. R. Schulz, M.V. Cohen, M. Behrends, J.M. Downey, and G. Heush Signal transduction of ischemic preconditioning Cardiovasc. Res. 52 2001 181 198
32. M.E. Speechly-Dick, G.J. Grover, and D.M. Yellon Does ischemic preconditioning in the human heart involve protein kinase C and the ATP-dependent K+ channel? Circ. Res. 77 1995 1030 1035
33. L. Talosi, and E.G. Kranias Effect of α-adrenergic stimulation on activation of protein kinase C and phosphorylation of proteins in intact rabbit hearts Circ. Res. 70 1992 670 678
34. The MIAMI Trial Research Group Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial Eur. Heart J. 6 1985 199 226
35. J.D. Thornton, J.F. Daly, M.V. Cohen, X.M. Yang, and J.M. Downey Catecholamines can induce adenosine receptor-mediated protected myocardium but do no participate in ischemic preconditioning in the rabbit Circ. Res. 73 1993 649 655
36. F. Tomai, F. Crea, A. Gaspadone, F. Versaci, A. Ghini, R. Paulis, L. Chiariello, and P. Gioffre Pentolamine prevents adaptation to ischemia during coronary angioplasty. Role of α-adrenergic receptors in ischemic preconditioning Circulation 96 1997 2171 2177
37. C.F. Toombs, A.L. Wiltse, and R.J. Shebushki Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium. Implication of norepinephrine release in the preconditioning effect Circulation 88 1993 2351 2358
38. I. Tritto, D. D'Andrea, N. Erano, A. Scognamiglio, C.D. Simone, A. Violante, A. Esposito, M. Chiarello, and G. Ambrosio Oxygen radicals can induce preconditioning in rabbit hearts Circ. Res. 80 1997 743 748
39. A. Tsuchida, T. Miura, T. Miki, K. Shimamoto, and O. Iimura Role of adenosine receptor activation in myocardial infarct size limitation by ischemic preconditioning Cardiovasc. Res. 26 1992 456 461
40. A. Tsuchida, Y. Liu, G.S. Liu, M.V. Cohen, and M.J. Downey α-Adrenergic agonists precondition rabbit heart ischemic myocardium independent of adenosine by direct activation of protein kinase C Circ. Res. 75 1994 576 585
41. R.S. Vander Heide, L.M. Schwartz, R.B. Jennings, and K.A. Reimer Effect of catecholamine depletion on myocardial infarct size in dogs: role of catecholamines in ischemic preconditioning Cardiovasc. Res. 30 5 1995 656 662
42. D.M. Walker, J.M. Walker, and W.B. Pugsley Preconditioning in isolated superfused human muscle J. Mol. Cell. Cardiol. 27 1995 1349 1357
43. P. Wang, K.P. Gallagher, J.M. Downey, and M.V. Cohen Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit hearts J. Mol. Cell. Cardiol. 28 1996 579 588
44. K. Yabe, H. Ishishita, K. Tanonaka, and S. Takeo Pharmacologic preconditioning induced by b-adrenegic stimulation is mediated by activation of protein kinase C J. Cardiovasc. Pharmacol. 32 1998 962 968
45. D.M. Yellon, A.M. Alkulaif, and W.B. Pugsley Preconditioning the human myocardium Lancet 342 1993 276 277
46. S. Yusuf, J. Wittes, and L. Friedman Overview of results of randomized clinical trials in heart disease. Treatments following myocardial infarction JAMA 260 1988 2088 2093